The story aired last Tuesday night and the piece was really great. We are getting a steady stream of calls from people with a wide range of issues seeking help. What we are not seeing is the expected explosion of response from people with dementia.

We were very pleased to have Ms. Stahl and her film crew come and interview some of the participants in the current clinical trial using the 1072mm infrared light stimulation protocol. We also had one of our clients who suffered a terrible brain injury in a work related incident tell her story.

Gordon Dougal, MD, inventor of the 1072nm near infrared light therapy and Dr. Marvin H. Berman, PhD will be speaking to residents and staff at The Watermark at Logan Square (2 Franklin Town Plaza) on the world's first early-stage dementia clinical trial being conducted at Quietmind Foundation.

Quietmind Associates president, Marvin H. Berman PhD will talk about alternative approaches to memory preservation and preventing dementia as part of our public education program. The program is for the residents of the Watermark at 1 Franklin Town Plaza on Monday 5/2/11 at 7-8pm.